Diagnostic Performance of Erythropoietin and Erythropoietin Receptors Levels in Children with Attention Deficit Hyperactivity Disorder.

Attention deficit hyperactivity disorder Erythropoietin Erythropoietin receptors

Journal

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332

Informations de publication

Date de publication:
31 Aug 2021
Historique:
received: 20 07 2020
revised: 04 10 2020
accepted: 05 11 2020
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 24 7 2021
Statut: ppublish

Résumé

Attention deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, a common childhood neurobehavioural disorder resulting from complex gene-gene and gene-environment interactions. The erythropoietin (Epo)/erythropoietin receptors (EpoR) system turned out to have additional important functions in nonhematopoietic tissue. In this study, we aimed to investigate the levels of Epo and and EpoR, and also their diagnostic values in children with ADHD. A total of 70 children were included in the study, 35 drug-naive patients with ADHD (age: 6-12 years; male/female: 20/15) and 35 healthy controls (age: 6-12 years; male/female: 22/13). Serum Epo and EpoR levels was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. The results indicated that the levels of Epo decreased in patients with ADHD compared to control (p < 0.05). On the other hand, EpoR levels increased in these patients (p < 0.05). Furthermore, the ratio of Epo/EpoR was significantly lower in ADHD patients than controls (p < 0.05). Receiver operator characteristic curve analysis showed high diagnostic performance for Epo and EpoR, areas under curve were 0.980 and 1.000, respectively. This is the first report to investigate the association between serum Epo and EpoR levels in ADHD patients. Our results indicated that Epo may play a role in the etiology of ADHD, and Epo therapy may be beneficial in these disorders if given in addition to the routine treatment of children with ADHD. Furthermore, our results reveal possible diagnostic value of Epo and EpoR.

Identifiants

pubmed: 34294622
pii: cpn.2021.19.3.530
doi: 10.9758/cpn.2021.19.3.530
pmc: PMC8316662
doi:

Types de publication

Journal Article

Langues

eng

Pagination

530-536

Références

Actas Esp Psiquiatr. 2009 Nov-Dec;37(6):352-8
pubmed: 20066587
Psychosom Med. 2009 Feb;71(2):171-86
pubmed: 19188531
J Clin Neurosci. 2007 Apr;14(4):364-8
pubmed: 17236773
Eur J Neurosci. 2003 Sep;18(6):1497-506
pubmed: 14511329
Clin Biochem. 2012 Jul;45(10-11):745-8
pubmed: 22497926
Psychiatry Res. 2013 Oct 30;209(3):638-42
pubmed: 23680468
Int J Dev Neurosci. 2008 Feb;26(1):103-11
pubmed: 17936539
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Ann Neurol. 2004 Dec;56(6):815-26
pubmed: 15470751
Clinics (Sao Paulo). 2012 Oct;67(10):1125-6
pubmed: 23070336
Neurotherapeutics. 2012 Jul;9(3):490-9
pubmed: 22976615
Biol Psychiatry. 2005 Jun 1;57(11):1215-20
pubmed: 15949990
Am J Psychiatry. 2007 Jun;164(6):942-8
pubmed: 17541055
Turk Psikiyatri Derg. 2007 Spring;18(1):48-58
pubmed: 17364268
Cell Death Differ. 2004 Jul;11 Suppl 1:S2-4
pubmed: 15243576
Biol Psychiatry. 2005 Jun 1;57(11):1336-46
pubmed: 15950006
J Abnorm Child Psychol. 1978 Jun;6(2):221-36
pubmed: 670589
Nutr J. 2016 Jul 25;15(1):71
pubmed: 27456681
Front Neuroendocrinol. 2014 Aug;35(3):331-46
pubmed: 24680800
Psychiatry Res. 2015 Sep 30;229(1-2):310-7
pubmed: 26188640
Lancet Psychiatry. 2016 Jun;3(6):555-67
pubmed: 27183902
Pediatr Neurol. 2000 Feb;22(2):115-21
pubmed: 10738916
Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):88-94
pubmed: 29397670
Arch Gen Psychiatry. 2012 Dec;69(12):1295-303
pubmed: 23070149
Blood. 2005 Jun 15;105(12):4604-12
pubmed: 15705783
J Neurosci. 2006 Jan 25;26(4):1269-74
pubmed: 16436614
Acta Neuropathol. 2001 Mar;101(3):271-6
pubmed: 11307627
J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):601-610
pubmed: 17450051

Auteurs

Meltem Gungor (M)

Department of Medical Biochemistry, Faculty of Medicine, Sanko University, Gaziantep, Turkey.

Ergul Belge Kurutas (EB)

Department of Medical Biochemistry, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey.

Erkan Oner (E)

Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.

Velid Unsal (V)

Faculty of Health Sciences and Central Research Laboratory, Mardin Artuklu University, Mardin, Turkey.

Hatice Altun (H)

Department of Child and Adolescent Psychiatry, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey.

Ali Erdinc Yalin (AE)

Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.

Serap Yalin (S)

Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.

Ozlem Bozkus (O)

Department of Medical Biochemistry, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey.

Nilfer Sahin (N)

Department of Child and Adolescent Psychiatry, Faculty of Medicine, Sitki Koçman University, Mugla, Turkey.

Classifications MeSH